(old print)
ITxM selected for participation in REDS III

ITxM selected for participation in REDS III
ITxM has been chosen as one of four domestic hubs for the Recipient Epidemiology and Donor Evaluation Study-III (REDSIII). The objectives of the REDSIII program are to improve blood component safety and availability, and assure safe and effective transfusion practices.

Sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, REDSIII will conduct epidemiological, laboratory, and survey research on transfused patients and U.S. blood donors. The study will help monitor the nation’s blood supply to detect any emerging diseases and determine ways to encourage more eligible people to donate blood.

Central Blood Bank, an ITxM Blood Center , and the University of Pittsburgh have a seven-year contract with NHLBI to participate in the REDSIII program, along with three other centers: the American Red Cross New England Region (with Yale), Blood Centers of the Pacific (with the University of California, San Francisco) and BloodCenter of Wisconsin.

The participation of ITxM/Central Blood Bank in the study will be led by primary investigator, Dr. Darrell Triulzi, along with co-investigators, Dr. Joseph Kiss and Dr. Ram Kakaiya, who is from the ITxM Chicago-based blood center, LifeSource. The selection of ITxM/Central Blood Bank as one of the hubs acknowledges the history of successful blood bank/transfusion medicine clinical trials at ITxM and the University of Pittsburgh.

"We are proud that we have been selected to participate in this important transfusion medicine study," said Dr. Triulzi, the Medical Director at ITxM. "The study will capitalize on ITxM Centralized Transfusion Services and its access to large numbers of patients and donors in an integrated database, as well as capitalize on the sophisticated comprehensive electronic medical record system at the University of Pittsburgh Medical Center."



Web site design and web site development by Americaneagle.com